Disulfiram is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Disulfiram.
| Product ID | 0093-5036_03847892-6961-4776-b673-04c901b0772e |
| NDC | 0093-5036 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Disulfiram |
| Generic Name | Disulfiram |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-07-19 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA088483 |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Substance Name | DISULFIRAM |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Acetyl Aldehyde Dehydrogenase Inhibitors [MoA],Aldehyde Dehydrogenase Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2011-07-19 |
| Marketing End Date | 2021-09-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA088483 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-07-19 |
| Ingredient | Strength |
|---|---|
| DISULFIRAM | 500 mg/1 |
| SPL SET ID: | a49396ee-da77-42df-b94c-130d2fb3dfbc |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0356 | Disulfiram | Disulfiram |
| 0054-0357 | Disulfiram | Disulfiram |
| 0093-5035 | Disulfiram | Disulfiram |
| 0093-5036 | Disulfiram | Disulfiram |
| 0378-4140 | Disulfiram | disulfiram |
| 0378-4141 | Disulfiram | disulfiram |
| 42794-028 | Disulfiram | Disulfiram |
| 47781-607 | Disulfiram | Disulfiram |
| 60429-196 | Disulfiram | Disulfiram |
| 62135-431 | Disulfiram | Disulfiram |
| 62135-432 | Disulfiram | Disulfiram |
| 64980-171 | Disulfiram | Disulfiram |
| 64980-172 | Disulfiram | Disulfiram |
| 68151-2694 | Disulfiram | Disulfiram |
| 51285-523 | Antabuse | Disulfiram |
| 51285-524 | Antabuse | Disulfiram |